Acetylcholine Chloride Phenolic NDC 44911-0025

NDC codes

FDA NDC Directory

Product NDC (as listed)44911-0025Labeler and product segments. Claims need a package NDC.

Product NDC at billing width44911-0025Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
44911-0025-1	44911002501	30 mL in 1 BOTTLE, DROPPER (44911-0025-1)Marketed from Nov 8, 2012

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Acetylcholine Chloride Phenolic
Generic name (nonproprietary): acetylcholine chloride,
Active ingredients: Acetylcholine chloride — 6 [hp_X]/mL
Dosage form: Liquid
Route: Oral
Labeler: Energique, Inc.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Nov 8, 2012
Listing expires: Dec 31, 2026
Other FDA classes: Cholinergic Agonists (Mechanism)
Identifiers: Product ID 44911-0025_687f604e-6337-4927-839c-788ec5db7d5dSPL ID 687f604e-6337-4927-839c-788ec5db7d5dSPL set ID 076587d3-46a0-48e5-9425-f5e1f5847ee3UNII AF73293C2RUPC 0363113600223
Pharmacologic class: Cholinergic Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N444911002501 followed by a unit qualifier and the quantity

Package 44911-0025-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 3, 2024.

Indications (excerpt from the label)

INDICATIONS: May temporarily relieve symptoms associated with reactions to actylcholine chloride, such as chest congestion with mild constriction. ** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)